Skip to main content
. 2022 Jun 30;8(7):e09836. doi: 10.1016/j.heliyon.2022.e09836

Figure 2.

Figure 2

Association of plasma Lp(a) and t-PA levels with ASCVD risk status. Baseline plasma lipoprotein a (Lp(a), A) and tissue plasminogen activator (t-PA, B) in patients with low risk of atherosclerosis cardiovascular disease (ASCVD), moderate risk, high risk, and very high risk. ∗∗p < 0.01 and ∗∗∗∗<0.0001 vs. Low. C is a scatter plot for log transformation of plasma Lp(a) and t-PA per ASCVD risk groups.